Toxicology Study Design for Peptide-Oligonucleotide Conjugate Therapeutics: A CRO Perspective
Introduction: The convergence of peptide chemistry and oligonucleotide biology has produced one of the most promising — and analytically demanding […]
Introduction: The convergence of peptide chemistry and oligonucleotide biology has produced one of the most promising — and analytically demanding […]
Introduction to Mass Spectrometry Characterization of Peptide-Oligonucleotide Conjugates Mass spectrometry characterization of peptide-oligonucleotide conjugates is a sophisticated, multi-dimensional analytical approach
Peptide-oligonucleotide conjugates (POCs) have emerged as an innovative class of chimeric therapeutics that integrate the exceptional sequence specificity of nucleic
Degradation Pathways of Peptide-Oligonucleotide Conjugates Under Stress Conditions Read More »
Strategic Frameworks for Bioanalytical Method Development for POC Therapeutics Establishing robust analytical assays for peptide-oligonucleotide conjugates requires highly specialized methodologies
What is the Scope of a CRO in IND-Enabling Studies for Peptide Oligonucleotide Conjugates? A specialized Contract Research Organization (CRO)
IND-Enabling Studies for POC Therapeutics: CRO Scope and Regulatory Deliverables Read More »
Introduction: GMP manufacturing of peptide-oligonucleotide conjugates sits at the intersection of two highly complex chemistries — and getting it right
GMP Manufacturing of Peptide-Oligonucleotide Conjugates: What to Expect from a CRO Read More »
Introduction: Peptide-Oligonucleotide Conjugates Impurity Profiling plays a critical role in the development of next-generation therapeutics such as antisense oligonucleotides, RNA
Introduction The comparison of Peptide vs Antibody Oligonucleotide Conjugates has become an important topic in the development of modern oligonucleotide
Comparison of POCs vs Antibody-Oligonucleotide Conjugates Read More »
Introduction: The primary therapeutic advantage of Peptide Oligonucleotide Conjugates Drug Delivery lies in its ability to enable precise, extrahepatic tissue
Drug Delivery Advantages of Peptide-Oligonucleotide Conjugates (POCs) Read More »
Introduction: Peptide-oligonucleotide conjugates (POCs) require carefully controlled strategies to remain stable because they combine two sensitive components—peptides and nucleic acids.
Stability Considerations for Peptide-Oligonucleotide Conjugates Read More »